GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
REPLY: Coding and Cybersecurity, Registration Is Now Open for the Reply Hack The Code Challenge 2025
Israel to free 90 prisoners in Saturday hostage swap: Palestinian NGO Reply has announced the opening of registrations for ...
Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO:2503) and Mitsui Norin Co., Ltd. (Mitsui Norin) are developing a ...
Clearwater Analytics (NYSE: CWAN), a leading worldwide provider of investment management, accounting, reporting, and analytics solutions, has appointed George Hindmarsh as Head of Sales and Business ...
Estée Lauder today announces that actor, writer, model and anti-ageism activist Paulina Porizkova, will return to the brand ...
SPIE, the international society for optics and photonics, recognized the top-rated new optics and photonics products with the ...
LTIM, BSE: 540005], a global technology consulting and digital solutions company, has partnered with FLS, a leading, full ...
Adtran today launched its Enhanced Short-Term Unit (ESTU) precision timing module, a new addition to its OSA 3300 ...
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of ...
Thales today announced a collaboration with the visual recognition technology company Eyedea, enabling the company to deploy ...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback